Windtree Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell WINT and other ETFs, options, and stocks.

About WINT

Windtree Therapeutics, Inc. is a clinical-stage biopharmaceutical and medical device company engaged in the development of novel therapeutics intended to address significant unmet medical needs in important acute care markets. It focuses on the treatment of acute cardiovascular and acute pulmonary diseases. 

CEO
Jed Andrew Latkin
CEOJed Andrew Latkin
Employees
14
Employees14
Headquarters
Warrington, Pennsylvania
HeadquartersWarrington, Pennsylvania
Founded
1992
Founded1992
Employees
14
Employees14

WINT Key Statistics

Market cap
2.78M
Market cap2.78M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
9.78M
Average volume9.78M
High today
$1.14
High today$1.14
Low today
$0.525
Low today$0.525
Open price
$0.8542
Open price$0.8542
Volume
78.67M
Volume78.67M
52 Week high
$737.44
52 Week high$737.44
52 Week low
$0.36
52 Week low$0.36

People also own

Based on the portfolios of people who own WINT. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.